Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Peter Borchmann


Peter Borchmann

University Hospital of Cologne


Peter Borchmann is Assistant Medical Director in the Department of Haematology and Oncology at the University Hospital of Cologne, Germany and head of the lymphoma programme including the CAR T-cell therapy phase I/II unit. He is head of the certified centre for haematological malignancies of the University Hospital of Cologne, Germany. As Co-Chairman of the German Hodgkin Study Group (GHSG) he is responsible for the development of investigator initiated clinical studies. He is an active member of the German Society for Haematology and Oncology (DGHO), the European Haematology Association (EHA), and the American Society of Haematology (ASH).

Last update: September 2020

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.